Erik Ahlstrand

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Venues

Cancers

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Anu Partanen, Anders Waage, Valdas Peceliunas, Schjesvold Fredrik, Pekka Anttila, Marjaana Säily, Katarina Uttervall, Mervi Putkonen, Kristina Carlson, Einar Haukas, Marja Sankelo, Damian Szatkowski, Markus Hansson, Anu Marttila, Ronald Svensson, Per Axelsson, Birgitta Lauri, Maija Mikkola, Conny Karlsson, Johanna Abelsson, Erik Ahlstrand, Anu Sikiö, Monika Klimkowska, Reda Matuzeviciene, Mona Hoysaeter Fenstad, Sorella Ilveskero, Tarja-Terttu Pelliniemi, Hareth Nahi, Raija Silvennoinen
Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group. Cancers 16 (5) (2024)
Anu Partanen, Anders Waage, Valdas Peceliunas, Schjesvold Fredrik, Pekka Anttila, Marjaana Säily, Katarina Uttervall, Mervi Putkonen, Kristina Carlson, Einar Haukas, Marja Sankelo, Damian Szatkowski, Markus Hansson, Anu Marttila, Ronald Svensson, Per Axelsson, Birgitta Lauri, Maija Mikkola, Conny Karlsson, Johanna Abelsson, Erik Ahlstrand, Anu Sikiö, Monika Klimkowska, Reda Matuzeviciene, Mona Hoysaeter Fenstad, Sorella Ilveskero, Tarja-Terttu Pelliniemi, Hareth Nahi, Raija Silvennoinen
Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group. Cancers 16 (5) (2024)
Marie Lindgren, Björn Andréasson, Jan Samuelsson, Helna Pettersson, Anneli Enblom-Larsson, Anna Ravn-Landtblom, Stefan Scheding, Carolina Bentham, Erik Ahlstrand
Survival and risk of vascular complications in myelofibrosis-A population-based study from the Swedish MPN group. European journal of haematology 109 (4) (2022)
Erik Ahlstrand, Jan Samuelsson, Marie Lindgren, Helna Pettersson, Maria Liljeholm, Anna Ravn-Landtblom, Stefan Scheding, Björn Andréasson
Highly reduced survival in essential thrombocythemia and polycythemia vera patients with vascular complications during follow-up. European journal of haematology 104 (3) (2020)

Erik Ahlstrand.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Erik Ahlstrand